Ruger Files Amended Proxy Statement Amidst Escalating Proxy Contest with Beretta, Proposes Significant Share Authorization Increase

summarizeSummary

Sturm, Ruger & Co. filed an amended preliminary proxy statement, detailing its strong opposition to activist investor Beretta Holding S.A.'s board nominees and proposing a significant increase in authorized shares amidst an escalating proxy contest.

check_boxKey Events

• Proxy Contest Escalates with Beretta Holding S.A.

  The company's Board is actively opposing the four director nominees put forth by activist investor and competitor Beretta Holding S.A., citing concerns over Beretta's self-interest and potential antitrust issues related to interlocking directorates. This follows a series of contentious interactions, including Ruger's adoption of a poison pill and rejection of Beretta's partial tender offer.

• Proposed Increase in Authorized Common Stock

  Shareholders will vote on a proposal to amend the Certificate of Incorporation to increase the number of authorized common stock from 40 million to 60 million shares. This 20 million share increase represents a potential dilution of 125.4% of current outstanding shares if all new shares were issued, providing the Board significant flexibility for future capital raises or strategic transactions.

• New Chief Financial Officer Appointed

  Andrew Wieland has been appointed as the new Senior Vice President and Chief Financial Officer, effective March 27, 2026, following the planned transition of Thomas A. Dineen.

• Update to Ongoing Proxy Battle

  This filing is an Amendment No. 1 to the preliminary proxy statement filed on April 1, 2026, providing updated details and the company's firm stance in the ongoing proxy contest ahead of the May 27, 2026 Annual Meeting.

auto_awesomeAnalysis

Sturm, Ruger & Co. has filed an amended preliminary proxy statement, intensifying its defense against activist investor Beretta Holding S.A. in an ongoing proxy contest. The company's Board is strongly opposing Beretta's four director nominees, citing concerns over self-interest and potential antitrust violations due to Beretta being a competitor. This filing provides a detailed history of the contentious interactions, including Ruger's prior adoption of a poison pill and rejection of Beretta's partial tender offer. Additionally, the company is seeking shareholder approval to increase its authorized common stock from 40 million to 60 million shares. If fully utilized, this 20 million share increase could lead to a substantial dilution of existing shareholders, representing 125.4% of current outstanding shares. The filing also announces the appointment of Andrew Wieland as the new Senior Vice President and Chief Financial Officer. This update underscores the high stakes of the upcoming annual meeting, with significant implications for corporate control, capital structure, and strategic direction.